The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis
Authors
Keywords
-
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-14
DOI
10.1186/s12885-019-6297-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation
- (2018) Jiangcheng Zuo et al. Cancer Biomarkers
- miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study
- (2018) Weronika Świtlik et al. Cancer Biomarkers
- MicroRNA-155 promotes gastric cancer growth and invasion by negatively regulating transforming growth factor-β receptor 2
- (2018) Yajing Qu et al. CANCER SCIENCE
- Prognostic value of microRNA-155 in human carcinomas: An updated meta-analysis
- (2018) Kangkang Liu et al. CLINICA CHIMICA ACTA
- Prognostic Role of MicroRNAs in Human Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
- (2018) Shree Ram Lamichhane et al. DISEASE MARKERS
- Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting
- (2018) Win Sen Heng et al. BIOCHEMICAL PHARMACOLOGY
- Involvement of miR-155/FOXO3a and miR-222/PTEN in acquired radioresistance of colorectal cancer cell line
- (2017) Hamed Manoochehri Khoshinani et al. JAPANESE JOURNAL OF RADIOLOGY
- Tumor Suppressor PTPRJ Is a Target of miR-155 in Colorectal Cancer
- (2017) Xiao-Fei Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer
- (2017) Mitsuo Tsukamoto et al. ONCOLOGY
- Involvement of miR-155/FOXO3a and miR-222/PTEN in acquired radioresistance of colorectal cancer cell line
- (2017) Hamed Manoochehri Khoshinani et al. Japanese Journal of Radiology
- Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer
- (2017) Jing Wang et al. Scientific Reports
- Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
- (2016) Katrien Van Roosbroeck et al. CLINICAL CANCER RESEARCH
- Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection
- (2016) Yi Hou et al. MEDICINE
- MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN
- (2016) Xinying Xue et al. Oncotarget
- Overview of MicroRNA Biology
- (2015) Ashley Mohr et al. SEMINARS IN LIVER DISEASE
- A functional variant in miR-155 regulation region contributes to lung cancer risk and survival
- (2015) Kaipeng Xie et al. Oncotarget
- Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments
- (2014) Carson Ka-Lok Lo et al. BMC Medical Research Methodology
- Cancer biomarker discovery: Current status and future perspectives
- (2014) Katrin Mäbert et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
- (2013) Penny F. Whiting ANNALS OF INTERNAL MEDICINE
- Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia
- (2013) Amal A. Abd-El-Fattah et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer
- (2013) Dongfang Tang et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients
- (2013) FENG GAO et al. ONCOLOGY REPORTS
- Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC
- (2013) Céline Sanfiorenzo et al. PLoS One
- MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression
- (2012) Y-S Zang et al. CANCER GENE THERAPY
- The Association of MicroRNA Expression with Prognosis and Progression in Early-Stage, Non-Small Cell Lung Adenocarcinoma: A Retrospective Analysis of Three Cohorts
- (2011) M. Saito et al. CLINICAL CANCER RESEARCH
- Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization
- (2011) Tom Donnem et al. Journal of Translational Medicine
- Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer
- (2011) Carina Roth et al. Molecular Oncology
- MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non-Small Cell Lung Carcinoma
- (2010) J. Voortman et al. CANCER RESEARCH
- MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer
- (2009) M. Raponi et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now